Deltagen(OTC) DGEN

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Deltagen last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-05
Deltagen stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002025-12-10
1 month+0%USD 0.002025-12-10
3 month+0%USD 0.002025-12-10
Year to date+0%USD 0.002025-12-10
1 year+0%USD 0.002025-04-08
3 year+0%USD 0.002023-05-04
5 year-99.97%USD 0.002021-06-04
Since inception-100%USD 10.322000-08-03

Deltagen Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.12M

Net Income (TTM)

$1.95M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

34.38 (High)

Price

$0.00

Volume

870

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Dec 13, 2024

DGEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Deltagen

Deltagen Inc. is a provider of drug discovery tools and services tailored for the biopharmaceutical industry. The company specializes in enhancing the efficiency of drug discovery through a suite of innovative programs, including access to biological models and drug targets.

Products and Services
  • Drug discovery tools for biopharmaceutical applications
  • Access to biological models and drug targets
  • Target validation data in immunology and metabolic diseases
Growth Outlook
  • Significant market potential in the biopharmaceutical sector
  • Increasing demand for efficient drug discovery solutions
  • Focus on expanding service offerings to meet industry needs
Financial Highlights
  • Recent quarterly revenue of 617,000, showing growth potential
  • Trailing twelve months (TTM) net profit margin of 28.9%
  • Current ratio of 2.30 indicates strong liquidity position
Deltagen Inc. operates in the healthcare sector, specifically within the medical instruments and supplies industry. The company has been incorporated since 1999 and is headquartered in San Mateo, California. With a market capitalization of approximately $3,859, Deltagen is positioned to leverage its innovative drug discovery tools to capture a growing share of the biopharmaceutical market. The recent quarterly revenue indicates a positive trend, while the TTM net profit margin reflects operational efficiency. The strong current ratio suggests that the company is well-equipped to meet its short-term obligations, making it an intriguing option for potential investors interested in the healthcare sector.
AI Generated • Sep 26, 2026

Industry

Life Sciences Tools and Services

Headquarters

San Mateo, CA 94403, US

DGEN Financials

Key Financial Metrics (TTM)

Gross Margin

29.28%

Operating Margin

29.28%

Net Income Margin

28.90%

Return on Equity

4.58%

Return on Capital

4.42%

Return on Assets

4.13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

38.59M

Volume

870

Avg. Volume

0

Financials (TTM)

Gross Profit

$5.12M

Operating Income

$3.09M

EBITDA

$612.00K

Operating Cash Flow

-$343.00K

Capital Expenditure

$0.00

Free Cash Flow

-$425.00K

Cash & ST Invst.

$2.67M

Total Debt

$0.00

Deltagen Performance Analysis

Deltagen sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32006-09-30-74.1%
Q42006-12-31227.7%
Q12007-03-31-88.7%
Q22007-06-3072.3%
Deltagen sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32006-09-30-90.8%
Q42006-12-311742.2%
Q12007-03-31-121.6%
Q22007-06-3069.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2007YOY CHG

Revenue

$617.00K

-83.5%

Gross Profit

$617.00K

-83.5%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$168.00K

-111.3%

EBITDA

-$227.00K

-112.2%

Quarterly Fundamentals

Name
Q2 2007YOY CHG

Total Cash

$2.67M

-75.2%

Total Debt

$0.00

N/A

Accounts Receivable

$1.71M

-49.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

4.13%

N/A

Return on Invested Capital

4.42%

N/A

Free Cash Flow

$336.00K

-76.9%

Operating Cash Flow

$348.00K

-76.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REMIRemedent, Inc.
$0.00+0.00%
THCTTHC Therapeutics, Inc.
$0.00+0.00%
NMXSNet Medical Xpress Solutions, Inc.
$0.00+0.00%
CYPSCyclo3pss Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.08-0.54%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$147.86+0.58%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$34.41-0.72%
TQQQProShares Trust - ProShares UltraPro Qqq
$78.03+0.74%

Questions About DGEN

What is the current price of Deltagen?

Deltagen is trading at $0.00 per share.

What is the 52-week range for Deltagen?

Over the past 52 weeks, Deltagen has traded between $0.00 and $0.00.

How much debt does Deltagen have?

Deltagen total debt is unavailable.

How much cash does Deltagen have on hand?

Deltagen does not have cash on hand data available.

What is Deltagen’s dividend yield?

Deltagen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.